Compare IDXX & FNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | FNV |
|---|---|---|
| Founded | 1983 | 1986 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.1B | 40.1B |
| IPO Year | 1991 | 2007 |
| Metric | IDXX | FNV |
|---|---|---|
| Price | $700.85 | $215.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $700.50 | $228.63 |
| AVG Volume (30 Days) | 592.4K | ★ 664.4K |
| Earning Date | 11-03-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | ★ 21.65 | N/A |
| EPS | ★ 12.60 | 4.77 |
| Revenue | ★ $4,167,411,000.00 | $1,531,400,000.00 |
| Revenue This Year | $12.15 | $58.77 |
| Revenue Next Year | $8.79 | $28.00 |
| P/E Ratio | $55.56 | ★ $45.11 |
| Revenue Growth | 8.39 | ★ 40.88 |
| 52 Week Low | $356.14 | $114.81 |
| 52 Week High | $769.98 | $225.64 |
| Indicator | IDXX | FNV |
|---|---|---|
| Relative Strength Index (RSI) | 49.31 | 65.80 |
| Support Level | $693.72 | $198.99 |
| Resistance Level | $716.45 | $207.11 |
| Average True Range (ATR) | 17.46 | 5.58 |
| MACD | -5.83 | 1.28 |
| Stochastic Oscillator | 13.64 | 79.65 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. The company's short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital. The company holds a portfolio of assets, diversified by commodity, revenue type, and stage of a project.